Cargando…
A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States
BACKGROUND: This cross-sectional study aimed to track population-based SARS-CoV-2 antibody seropositivity duration across the United States using observational data from a national clinical laboratory registry of patients tested by nucleic acid amplification (NAAT) and serologic assays. Knowledge of...
Autores principales: | Alfego, David, Sullivan, Adam, Poirier, Brian, Williams, Jonathan, Adcock, Dorothy, Letovsky, Stanley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143650/ https://www.ncbi.nlm.nih.gov/pubmed/34056568 http://dx.doi.org/10.1016/j.eclinm.2021.100902 |
Ejemplares similares
-
Follow-Up SARS-CoV-2 PCR Testing Outcomes From a Large Reference Lab in the US
por: Sullivan, Adam, et al.
Publicado: (2021) -
Antibody titer levels and the effect on subsequent SARS-CoV-2 infection in a large US-based cohort
por: Sullivan, Adam, et al.
Publicado: (2023) -
Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States
por: Kalish, Heather, et al.
Publicado: (2021) -
Longevity of seropositivity after anti SARS-CoV-2 vaccination in patients awaiting liver transplant
por: Calleri, A., et al.
Publicado: (2022) -
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
por: Liu, Anding, et al.
Publicado: (2020)